Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury

Summary

The most common toxicity of TP (docetaxel and cisplatin) chemotherapy is chemotherapy-induced liver injury. However, patients don't always experience same chemotherapy-induced liver injury for the same drugs. Therefore, the investigators designed the present study to clarify risk factors associated with the development of severe hepatotoxicity after therapy with docetaxel and cisplatin for nasopharyngeal carcinoma (NPC).

Timeline

Start

2017-02-10

Primary completion

2018-01-01

Completion

2018-01-01

Drugs

Indications